170 related articles for article (PubMed ID: 26561367)
1. In alcoholic cirrhosis, low-serum hepcidin levels associate with poor long-term survival.
Nahon P; Nuraldeen R; Rufat P; Sutton A; Trautwein C; Strnad P
Liver Int; 2016 Feb; 36(2):185-8. PubMed ID: 26561367
[TBL] [Abstract][Full Text] [Related]
2. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
[TBL] [Abstract][Full Text] [Related]
5. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
[TBL] [Abstract][Full Text] [Related]
6. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
7. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
[TBL] [Abstract][Full Text] [Related]
8. CHOP-mediated hepcidin suppression modulates hepatic iron load.
Mueller K; Sunami Y; Stuetzle M; Guldiken N; Kucukoglu O; Mueller S; Kulaksiz H; Schwarz P; Strnad P
J Pathol; 2013 Dec; 231(4):532-42. PubMed ID: 23749468
[TBL] [Abstract][Full Text] [Related]
9. Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.
Nault JC; Guyot E; Laguillier C; Chevret S; Ganne-Carrie N; N'Kontchou G; Beaugrand M; Seror O; Trinchet JC; Coelho J; Lasalle P; Charnaux N; Delehedde M; Sutton A; Nahon P
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1343-52. PubMed ID: 23780836
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
11. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
[TBL] [Abstract][Full Text] [Related]
14. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload.
Fernández-Ruiz M; Parra P; Ruiz-Merlo T; López-Medrano F; San Juan R; Polanco N; González E; Andrés A; Aguado JM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29120522
[TBL] [Abstract][Full Text] [Related]
15. Is iron overload in alcohol-related cirrhosis mediated by hepcidin?
Iqbal T; Diab A; Ward DG; Brookes MJ; Tselepis C; Murray J; Elias E
World J Gastroenterol; 2009 Dec; 15(46):5864-6. PubMed ID: 19998511
[TBL] [Abstract][Full Text] [Related]
16. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study.
Ganne-Carrié N; Christidis C; Chastang C; Ziol M; Chapel F; Imbert-Bismut F; Trinchet JC; Guettier C; Beaugrand M
Gut; 2000 Feb; 46(2):277-82. PubMed ID: 10644325
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P
J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
